Beta-adrenoceptor (also called β-adrenoceptor or beta-adrenergic receptor) (β-adrenoceptor (alternative: β-AR))

Beta-adrenoceptors are a family of G protein-coupled receptors that mediate the effects of the endogenous catecholamines, norepinephrine and epinephrine, on target cells throughout the body. They are classified into three main subtypes: beta-1, beta-2, and beta-3, which are differentially distributed and mediate distinct physiological functions such as cardiac stimulation (beta-1), bronchodilation and smooth muscle relaxation (beta-2), and adipocyte lipolysis (beta-3). These receptors are crucial targets for a variety of pharmacological agents, including agonists (e.g., isoproterenol, dobutamine) used in acute cardiovascular emergencies, and antagonists (beta-blockers: propranolol, metoprolol) widely prescribed in hypertension, arrhythmias, and heart failure. Beta-adrenoceptor dysfunction or genetic variants are associated with a range of diseases including cardiovascular, metabolic, and respiratory conditions. Monitoring and therapeutic manipulation of beta-adrenoceptors remain a central strategy in modern medicine.

Other names

Beta-adrenergic receptorAdrenergic beta receptorBeta-adrenoceptorβ-adrenergic receptorβ-adrenoceptorβ-receptorADRB

Agonists: activate beta-adrenoceptors, leading to increased cAMP and subsequent activation of protein kinase A, causing increased heart rate, contractility, bronchodilation, renin release, and lipolysis depending on the subtype and tissue. Antagonists (Beta-blockers): inhibit the action of endogenous catecholamines on beta-adrenoceptors, leading to reduced heart rate, blood pressure, and cardiac output.